Skip to main content

8 Result(s)

within W G Morice Remove this filter

and

  1. No Access

    Article

    Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

    The presence of high numbers of circulating clonal plasma cells (cPCs) in patients with smoldering multiple myeloma (SMM), detected by a slide-based immunofluorescence assay, has been associated with a shorter...

    W I Gonsalves, S V Rajkumar, A Dispenzieri, D Dingli, M M Timm, W G Morice… in Leukemia (2017)

  2. No Access

    Article

    Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma

    The presence of clonal circulating plasma cells (cPCs) is a marker of high-risk disease in all stages of monoclonal gammopathies. However, the prognostic utility of quantitating cPCs using multiparametric flow...

    W I Gonsalves, S V Rajkumar, V Gupta, W G Morice, M M Timm, P P Singh… in Leukemia (2014)

  3. No Access

    Article

    High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma

    Smoldering multiple myeloma (SMM) carries a 50% risk of progression to multiple myeloma (MM) or related malignancy within the first 5 years following diagnosis. The goal of this study was to determine if high ...

    G Bianchi, R A Kyle, D R Larson, T E Witzig, S Kumar, A Dispenzieri, W G Morice… in Leukemia (2013)

  4. No Access

    Article

    Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets

    W G Morice, D Jevremovic, H Olteanu, A Roden, G Nowakowski, S Kroft, C A Hanson… in Leukemia (2010)

  5. No Access

    Article

    Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas

    Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed. The recent finding of SYK/ITK translocations in rare P...

    A L Feldman, D X Sun, M E Law, A J Novak, A D Attygalle, E C Thorland, S R Fink… in Leukemia (2008)

  6. No Access

    Article

    Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al.

    P T Greipp, P Kapoor, W G Morice, T E Witzig, P R Greipp in Leukemia (2008)

  7. No Access

    Article

    Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders

    W G Morice, C A Hanson, S Kumar, L A Frederick, C E Lesnick, P R Greipp in Leukemia (2007)

  8. No Access

    Article

    NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis

    W G Morice, W R Macon, A Dogan, C A Hanson, P J Kurtin in Leukemia (2006)